At 5.0% CAGR, the South & Central America ELISA Diagnostics Tests Market is Projected to be worth US$ 129.69 million by 2030, says Business Market Insights
According to Business Market Insights research, the South & Central America ELISA diagnostics tests market was valued at US$ 87.77 million in 2022 and is expected to reach US$ 129.69 million by 2030, registering a CAGR of 5.0% from 2022 to 2030. Advancements in ELISA-Based procedures and rising incidence of human infections are among the critical factors attributed to the South & Central America ELISA diagnostics tests market expansion.
The use of ELISA for in-vitro diagnostics (IVD) has gained considerable attention in the global market. Researchers from various fields have been attracted to the development and application of ELISA-based procedures through techniques such as magnetic beads, paper-based platforms, and nanomaterials. Other examples of technology-based ELISA kits are digital ELISA, Multiplex ELISA, Single-Molecule ELISA, Nanoparticle-Based ELISA, and Smartphone-Based ELISA. Also, companies launch ELISA testing kits based on several techniques for fast and efficient clinical results. The "AMP'D ELISA Signal Amplification system" is manufactured by Enzo Life Sciences, Inc. The AMP'D Technology efficiently improves the sensitivity of sandwich ELISA test type with a single amplification kit and offers high sensitivity.
Cell Signaling Technology, Inc.'s "PathScan Phospho-RSK1 (Ser380) Sandwich ELISA Kit," designed by Cell Signaling Technology, is another example of a technology-advanced ELISA test kit product. Such advanced technology-based ELISA test kit products will have a high demand in the future by veterinarian for the detection of different species responsible for veterinary and human-associated infections or diseases. Therefore, advancements in ELISA-based procedures are expected to bolster the ELISA diagnostic test market growth during 2020-2030. ELISA diagnostic test.
On the contrary, incidents of product recalls hamper the growth of South & Central America ELISA diagnostics tests market.
Based on adoption, the South & Central America ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held 65.9% market share in 2022, amassing US$ 57.86 million. It is projected to garner US$ 88.57 million by 2030 to expand at 5.5% CAGR during 2022-2030.
In terms of test type, the South & Central America ELISA diagnostics tests market is categorized into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held 35.4% share of South & Central America ELISA diagnostics tests market in 2022, amassing US$ 31.06 million. It is projected to garner US$ 50.18 million by 2030 to expand at 6.2% CAGR during 2022-2030.
Based on application, the South & Central America ELISA diagnostics tests market is categorized into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held 41.2% share of South & Central America ELISA diagnostics tests market in 2022, amassing US$ 36.20 million. It is projected to garner US$ 57.87 million by 2030 to expand at 6.0% CAGR during 2022-2030.
By end user, the South & Central America ELISA diagnostics tests market is categorized into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held 40.3% share of South & Central America ELISA diagnostics tests market in 2022, amassing US$ 35.41 million. It is projected to garner US$ 56.05 million by 2030 to expand at 5.9% CAGR during 2022-2030.
Based on country, the South & Central America ELISA diagnostics tests market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 42.3% share of South & Central America ELISA diagnostics tests market in 2022. It was assessed at US$ 37.13 million in 2022 and is likely to hit US$ 56.91 million by 2030, exhibiting a CAGR of 5.5% during 2022-2030.
Key players operating in the South & Central America ELISA diagnostics tests market are Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., DiaSorin SpA, and Elabscience Biotechnology Inc., among others.
In June 2021, Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products.
In June 2023, IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry's Most Comprehensive Renal Testing Portfolio.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com
